Among significant news last week, the US Food and Drug Administration (FDA) required Agios Pharmaceuticals to amend the label ...
Physicians or patients who wish to participate in the 60 Degrees Pharmaceuticals Tafenoquine for Babesiosis Expanded Access clinical study are encouraged to visit the Company’s website for information ...
Inaticabtagene autoleucel is under clinical development by Juventas Cell Therapy and currently in Phase I for Acquired (Autoimmune) Hemolytic Anemia. According to GlobalData, Phase I drugs for ...
When they occur, symptoms of mild anemia are subtle and can often be overlooked. You may not know you have this disorder until your blood is tested. When beta thalassemia minor results in mild ...
Six female and four male patients completed the study. One patient received rituximab previously for treatment of autoimmune hemolytic anemia more than 12 months ago (Table 1). Based on these results, ...
When you don’t get enough iron, you can develop iron deficiency anemia (IDA). In IDA, you cannot make enough healthy red blood cells to carry oxygen throughout your body. There are many ...
Anemia is more common in later-stage chronic kidney disease (CKD), with diabetes and dialysis increasing the risk. Treating the underlying cause can improve symptoms and quality of life. It’s ...
The early treatment of anemia in eligible patients with MF should be a primary consideration according to the review. Patients with different types of myelofibrosis (MF) and anemia, their traditional ...
SAN DIEGO—Pediatric patients with autoimmune hemolytic anemia (AIHA), including cold agglutinin disease (CAD), have a high rate of morbidity and mortality according to a study presented at the 2024 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback